0
0
Home » Medical Devices

COVID-19 Impact on F. Hoffmann-La Roche Ltd.’s Revenue and Operations (Medical Devices)

F. Hoffmann-La Roche Ltd. (Roche) is a biotechnology company that develops drugs and diagnostics to treat major diseases, headquartered in Switzerland with global manufacturing and sales reach. Roche provides pharmaceuticals in oncology, immunology, neuroscience, ophthalmology, infectious diseases, respiratory and other therapeutic areas. The company also provides in vitro diagnostics and tissue-based cancer diagnostics, as well as diabetes management solutions. The report, COVID-19 Impact on F. Hoffmann-La Roche Ltd.'s Revenue and Operations (Medical Devices) presents a deep dive analysis into how F. Hoffmann-La Roche Ltd. is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.

Scope

The report provides a comprehensive analysis of the impact of COVID-19 on F. Hoffmann-La Roche Ltd. –

– It provides insights on F. Hoffmann-La Roche Ltd.'s exposure to the regions and businesses impacted by the COVID-19 outbreak.

– It offers an overview of the company’s revenue impact by region and market for 2020 due to the COVID-19 outbreak.

Key Highlights

The spread of the disease in recent months has caused volatility in some markets, but has had a limited impact on Roche’s business performance.

Roche announced that during Q3 2020, Diagnostic Division sales grew 9% compared to Q1 2019 with a 29% growth in sales of molecular testing as the main contributor. Roche launched several new diagnostic tools in the fight against COVID-19: the SARS-CoV-2 rapid antigen test, cobas SARS-CoV-2 & influenza A/B test and Elecsys AntiSARS-CoV-2 S antibody test. Roche's SARS-CoV-2 & Influenza A/B Test for use on the cobas® 6800/8800 Systems has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA)

Reasons to Buy

An overview of how F. Hoffmann-La Roche Ltd. will be affected by the COVID-19 pandemic.

Key Players

F. Hoffmann-La Roche Ltd.

Table of Contents

Table of Contents

COVID-19 impact analysis on Roche – Key Findings

Roche Key Facts

Geographic spread analysis – COVID-19 vs Roche sales

The impact of COVID-19 on regional GDP per capita levels

Roche's exposure: revenues by region and market vs regional impact levels

Roche's : revenue impact by region and market for 2020

Operational reactions from Roche? Indications from recruitment trends

Operational reactions from Roche’s Indications from US pricing trends

Contact us

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2960

Join our mailing list

Saved reports